Merion Station, PA, United States of America

Aimee S Payne

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Aimee S Payne: Innovator in Chimeric Antigen Receptors and HIV Treatment

Introduction

Aimee S Payne, a distinguished inventor located in Merion Station, PA, has made significant strides in the field of immunology and biotechnology. With 12 patents to her name, her research focuses on harnessing the power of T cells for innovative therapies against cancer and HIV.

Latest Patents

Among her latest innovations, Payne has developed compositions and methods for targeting γδ T cells with chimeric antigen receptors. This groundbreaking invention includes a chimeric antigen receptor (CAR) specifically designed for an anti-γδ T cell receptor (anti-γδ TCR CAR), alongside vectors and recombinant T cells or other effector cells that express this CAR. The invention provides methods to engineer T cells that target γδ T cells, enhancing the potential for targeted cancer therapies.

Another notable patent of hers pertains to the method of redirecting T cells to treat HIV infection. This invention details compositions and methods aimed at treating HIV-infected mammals using a modified T cell featuring a CD4 membrane-bound chimeric receptor or HIV-specific single-chain variable fragments (scFvs CARs). The development of these modified T cells, along with pharmaceutical compositions for adoptive cell therapy, showcases Aimee's commitment to addressing critical healthcare challenges.

Career Highlights

Aimee S Payne is affiliated with the University of Pennsylvania, where she contributes her expertise in biology and immunotherapy. Her research has had a profound impact on the field, particularly in developing innovative treatments that leverage the body’s immune response to combat diseases.

Collaborations

Throughout her career, Aimee has collaborated with notable colleagues, including Christoph T Ellebrecht and Michael C Milone, enhancing her research's effectiveness and broadening the scope of innovative solutions in her field.

Conclusion

Aimee S Payne exemplifies the ingenuity and dedication of modern inventors in the fight against diseases such as cancer and HIV. With her extensive portfolio of patents and focus on chimeric antigen receptors, she continues to advance the boundaries of medical research and innovation. Her work at the University of Pennsylvania is a testament to the importance of collaboration and creative thinking in developing impactful healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…